Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2024-12-31 |
2024-01-01 to 2024-12-31 |
As at 2023-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Legal form of entity | — |
A/S
|
— |
| Country of incorporation | — |
Denmark
|
— |
| Address of entity's registered office | — |
Philip Heymans Alle 3, DK-2900 Hellerup
|
— |
| Principal place of business | — |
global
|
— |
| Description of nature of entity's operations and principal activities | — |
in vaccine research, development, and
|
— |
| Name of parent entity | — |
Bavarian Nordic A/S
|
— |
| Statement of IFRS compliance [text block] | — |
Basis of preparation
|
— |
| Disclosure of reclassifications or changes in presentation [text block] | — |
The grant of the initial restricted stock units to the Exec-
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
2,327,309,000
DKK
|
— |
1,643,736,000
DKK
|
| Current trade receivables |
1,175,744,000
DKK
|
— |
1,778,104,000
DKK
|
| Current trade payables |
1,045,134,000
DKK
|
— |
954,142,000
DKK
|
| Disclosure of material accounting policy information [text block] | — |
Note 1
|
— |